ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年01月30日 09時00分
Source:
Eisai
エーザイ、中国における新型コロナウイルス関連肺炎への対応活動支援について
東京, 2020年01月30日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫)は、このたび、中華人民共和国(以下、中国)の湖北省武漢市を中心に感染が広がっている新型コロナウイルス関連肺炎について、現地での対応活動を支援するため、当社の中国子会社を通じて、非営利団体である武漢市慈善総会(武汉市慈善总会)に100万元(日本円で約1600万円)の義援金を寄付することを決定しました。また、現地の医療機関に対して、医薬品の提供を行います。
中国における新型コロナウイルス関連肺炎患者様の早期回復と感染の終息を心より祈念いたします。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202007.html
概要:エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
NEC completes construction of approximately 2,250 km EMCS submarine cable linking Pacific island nations
May 15, 2026 17:36 JST
Fujitsu and Science Tokyo launch joint research hub for quantum hardware advancement and talent development
May 15, 2026 17:12 JST
Fujitsu and IBM Japan formalize collaboration in healthcare sector
May 15, 2026 16:42 JST
Toyota Launches All-New Land Cruiser "FJ" Series in Japan
May 15, 2026 15:24 JST
Mitsubishi Motors Signs Memorandum of Understanding with FPT Japan Holdings to Study Collaboration in Software and Digital Domain
May 15, 2026 15:10 JST
NEC Launches Orbital Transfer Vehicle Development Project Aiming for Asia's First Vehicle Deployment through JAXA's Space Strategy Fund Program
May 15, 2026 14:55 JST
JCB and Discover(R) Network Mark 20 Years of Collaboration
May 14, 2026 23:00 JST
Asset Value Investors (AVI) urges the dismissal of two directors at Wacom
May 14, 2026 17:00 JST
Euro Manganese Announces Positive Preliminary Economic Assessment
May 14, 2026 13:29 JST
Event Report: TBS Group's Akanetsu Holds Commissioning Ceremony for Hydrogen Heat Source Facility
May 13, 2026 19:00 JST
SPARX Group Establishes "Mirai Creation Fund IV" Toyota Motor Corporation, Sumitomo Mitsui Banking Corporation, MUFG Bank, Ltd. and Mizuho Bank, Ltd. to Provide Capital Targeting Total Commitments of JPY100 billion
May 12, 2026 19:29 JST
JCB and Credit Card Association of the Philippines (CCAP) Launch Partnership to Boost Financial Literacy Among Filipinos
May 12, 2026 14:00 JST
Aleen Inc. Announces Its OTC Market Listing
May 12, 2026 10:30 JST
Fujitsu Digitalizes Management of Japan's Reserve Self-Defense Force for Ministry of Defense, Enhancing Efficiency
May 07, 2026 14:02 JST
ULVAC Establishes Japan-Based Production for Rare-Earth Magnet Vacuum Melting Furnaces
May 01, 2026 11:00 JST
teamLab Borderless Ranked Among the World's 100 Most Visited Art Museums and 4th in Japan
Apr 30, 2026 21:00 JST
TANAKA to Showcase Advanced Semiconductor Materials and Circular Economy Initiatives at SEMICON Southeast Asia 2026
Apr 28, 2026 21:00 JST
NEC Launches "Africa Corporate Innovation Program" Accelerating Business Through Co-Creation with African Startups
Apr 28, 2026 19:05 JST
Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
Apr 28, 2026 01:00 JST
NEC Announces Strategic Collaboration with Anthropic Focused on Enterprise AI
Apr 23, 2026 17:46 JST
More Latest Release >>
Related Release
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
4/21/2026 8:52:00 PM JST
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
3/27/2026 8:14:00 PM JST
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
3/27/2026 6:19:00 PM JST
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
3/23/2026 11:19:00 AM JST
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
3/19/2026 10:54:00 AM JST
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
3/17/2026 7:49:00 PM JST
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
3/12/2026 5:21:00 PM JST
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting
3/11/2026 12:07:00 PM JST
WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
3/2/2026 9:49:00 AM JST
Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy
2/16/2026 2:03:00 PM JST
More Press release >>